Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Irritable Bowel Syndrome, February 2023 Free Subscription Abstracts Retrieve all available abstracts of the following 72 articles: HTML format

Single Articles

1. MAYER EA, Ryu HJ, Bhatt RR
   The neurobiology of irritable bowel syndrome.
   Mol Psychiatry. 2023 Feb 2. doi: 10.1038/s41380-023-01972.
   PubMed    
   Abstract available
   
   

2. BOSMAN MHMA, Weerts ZZRM, Snijkers JTW, Vork L, et al
   The socioeconomic impact of irritable bowel syndrome: an analysis of direct and indirect healthcare costs.
   Clin Gastroenterol Hepatol. 2023 Jan 30:S1542-3565(23)00076.
   PubMed    
   Abstract available
   
   

3. MORENO-LIGERO M, Moral-Munoz JA, Salazar A, Failde I, et al
   mHealth Intervention for Improving Pain, Quality of Life, and Functional Disability in Patients With Chronic Pain: Systematic Review.
   JMIR Mhealth Uhealth. 2023;11:e40844.
   PubMed    
   Abstract available
   
   

4. YUAN S, Chen J, Ruan X, Sun Y, et al
   Smoking, Alcohol consumption, and 24 Gastrointestinal Diseases: Mendelian Randomization Analysis.
   Elife. 2023;12:e84051.
   PubMed    
   Abstract available
   
   

5. VAN THIEL I, de Jonge W, van den Wijngaard R
   Fungal feelings in the irritable bowel syndrome: the intestinal mycobiome and abdominal pain.
   Gut Microbes. 2023;15:2168992.
   PubMed    
   Abstract available
   
   

6. CLAASSEN PL, Hinojosa T, Rai A, Riddle MS, et al
   Examining Clinical Presentation and Workup of Veterans with Irritable Bowel Syndrome in a Single Medical Centre: A Case Series.
   J Mil Veterans Health. 2022;30:22-26.
   PubMed    
   Abstract available
   
   

7. TANG B, Hu Y, Chen J, Su C, et al
   Oral and fecal microbiota in patients with diarrheal irritable bowel syndrome.
   Heliyon. 2023;9:e13114.
   PubMed    
   Abstract available
   
   

8. HIZAY A, Dag K, Oz N, Comak-Gocer EM, et al
   Lactobacillus acidophilus regulates abnormal serotonin availability in experimental ulcerative colitis.
   Anaerobe. 2023;80:102710.
   PubMed    
   Abstract available
   
   

9. SIMREN M
   Targeting the gut microenvironment in IBS to improve symptoms.
   Nat Rev Gastroenterol Hepatol. 2023;20:69-70.
   PubMed    
   
   
   

10. FAROKHI-FARD A, Bayat E, Beig Parikhani A, Komijani S, et al
    Bacterial production and biophysical characterization of a hard-to-fold scFv against myeloid leukemia cell surface marker, IL-1RAP.
    Mol Biol Rep. 2023;50:1191-1202.
    PubMed    
    Abstract available
    
    

11. VEDANTAM S, Graff E, Khakoo NS, Khakoo NS, et al
    Food as Medicine: How to Influence the Microbiome and Improve Symptoms in Patients with Irritable Bowel Syndrome.
    Curr Gastroenterol Rep. 2023 Feb 10. doi: 10.1007/s11894-023-00861.
    PubMed    
    Abstract available
    
    

12. MONEM SMA, Elbadrawy EG, Shalaby SM, Hendawy DM, et al
    The role of serum gastric peptide ghrelin hormone level in irritable bowel syndrome at Zagazig University Hospitals.
    J Med Life. 2022;15:1525-1531.
    PubMed    
    Abstract available
    
    

13. KHATIB MA, Aljaaly EA
    Testing the Arabic-Saudi Arabia version of the Rome IV Diagnostic Questionnaire for functional gastrointestinal disorders for Children living in Saudi Arabia.
    Front Pediatr. 2023;10:1055513.
    PubMed    
    Abstract available
    
    

14. GUO C, Che X, Briese T, Ranjan A, et al
    Deficient butyrate-producing capacity in the gut microbiome is associated with bacterial network disturbances and fatigue symptoms in ME/CFS.
    Cell Host Microbe. 2023;31:288-304.
    PubMed    
    Abstract available
    
    

15. WICKRAMASINGHE D, Kamburugamuwa S, Xavier C, Samarasekera N, et al
    Prevalence of irritable bowel syndrome and its association with colorectal cancer: a systematic review and meta-analysis.
    ANZ J Surg. 2023 Feb 9. doi: 10.1111/ans.18223.
    PubMed    
    Abstract available
    
    

16. TANG H, Chen X, Huang S, Yin G, et al
    Targeting the gut-microbiota-brain axis in irritable bowel disease to improve cognitive function - recent knowledge and emerging therapeutic opportunities.
    Rev Neurosci. 2023 Feb 10. doi: 10.1515/revneuro-2022-0155.
    PubMed    
    Abstract available
    
    

17. RUEDA-RUZAFA L, Roman P, Cardona D, Requena M, et al
    Environmental pesticide exposure and the risk of irritable bowel syndrome: A case-control study.
    Environ Toxicol Pharmacol. 2023;98:104076.
    PubMed    
    Abstract available
    
    

18. GONG W, Guo P, Li Y, Liu L, et al
    Role of the Gut-Brain Axis in the Shared Genetic Etiology Between Gastrointestinal Tract Diseases and Psychiatric Disorders: A Genome-Wide Pleiotropic Analysis.
    JAMA Psychiatry. 2023 Feb 8:e224974. doi: 10.1001/jamapsychiatry.2022.4974.
    PubMed    
    Abstract available
    
    

19. BOGUT A, Martinac M, Pravdic D, Karin M, et al
    Personality Traits and Health Related Quality of Life in Patients with Irritable Bowel Sindrome and Inflammatory Bowel Disease.
    Psychiatr Danub. 2022;34.
    PubMed    
    Abstract available
    
    

20. BRUCE H, Osypiw J, Prajapati-Jha G, O'Driscoll S, et al
    Comparison of faecal calprotectin using two collection and extraction strategies for the BAHLMANN CALEXA(R) Cap a possible implications for clinical cut-offs?
    Ann Clin Biochem. 2023 Feb 7:45632231159296. doi: 10.1177/00045632231159296.
    PubMed    
    Abstract available
    
    

21. SAAVEDRA FARACH M, Astuquipan H
    [Presence of anxiety and depression in gastroenterology outpatients in Metropolitan Lima].
    Rev Gastroenterol Peru. 2022;42:171-176.
    PubMed    
    Abstract available
    
    

22. TUTEJA AK, Talley NJ, Murtaugh MA, Loc-Carrillo CM, et al
    Randomized, Double-Blind Placebo-Controlled Trial to Assess the Effect of Probiotics on Irritable Bowel Syndrome in Veterans With Gulf War Illness.
    Fed Pract. 2022;39:410-417.
    PubMed    
    Abstract available
    
    

23. CONG X, Li Y, Bian R
    Relationship between Neuroticism and Gastrointestinal Symptoms in Irritable Bowel Syndrome: The Mediating Role of Sleep.
    Iran J Public Health. 2022;51:1999-2006.
    PubMed    
    Abstract available
    
    

24. ZOURIDIS S, Ashraf MF, Tempera P, Abulawi A, et al
    A Comparison of the Effects of COVID-19 on Irritable Bowel Syndrome and Inflammatory Bowel Disease Patients While Working at Home and in the Office: A Retrospective Study.
    Cureus. 2023;15:e33266.
    PubMed    
    Abstract available
    
    

25. CHANG L, Cash BD, Lembo A, Kunkel DC, et al
    Efficacy and safety of olorinab, a full agonist of the cannabinoid receptor 2, for the treatment of abdominal pain in patients with irritable bowel syndrome: Results from a phase 2b randomized placebo-controlled trial (CAPTIVATE).
    Neurogastroenterol Motil. 2023 Feb 5:e14539. doi: 10.1111/nmo.14539.
    PubMed    
    Abstract available
    
    

26. TANNER SE, Burton Murray H, Brown TA, Malik Z, et al
    Gastrointestinal-Specific symptom anxiety in patients with gastroparesis: Relationships to symptom severity and quality of life.
    Neurogastroenterol Motil. 2023 Feb 5:e14534. doi: 10.1111/nmo.14534.
    PubMed    
    Abstract available
    
    

27. CHEN J, Yuan S, Fu T, Ruan X, et al
    Gastrointestinal Consequences of Type 2 Diabetes Mellitus and Impaired Glycemic Homeostasis: A Mendelian Randomization Study.
    Diabetes Care. 2023 Feb 17:dc221385. doi: 10.2337/dc22-1385.
    PubMed    
    Abstract available
    
    

28. BALAKRISHNAN G, Bhat A, Naik D, Kim JS, et al
    Gelatin-based Ingestible Impedance Sensor to Evaluate Gastrointestinal Epithelial Barriers.
    Adv Mater. 2023 Feb 17:e2211581. doi: 10.1002/adma.202211581.
    PubMed    
    Abstract available
    
    

29. WALLACE C, Gordon M, Sinopoulou V, Akobeng AK, et al
    Probiotics for management of functional abdominal pain disorders in children.
    Cochrane Database Syst Rev. 2023;2:CD012849.
    PubMed    
    Abstract available
    
    

30. WIREDU OCANSEY DK, Hang S, Yuan X, Qian H, et al
    The diagnostic and prognostic potential of gut bacteria in inflammatory bowel disease.
    Gut Microbes. 2023;15:2176118.
    PubMed    
    Abstract available
    
    

31. KUMAR K, Appleby-Gunnill B, Maslin K
    Nutritional practices and dietetic provision in the endometriosis population, with a focus on functional gut symptoms.
    J Hum Nutr Diet. 2023 Feb 16. doi: 10.1111/jhn.13158.
    PubMed    
    Abstract available
    
    

32. D'SILVA A, Marshall DA, Vallance JK, Nasser Y, et al
    Gastroenterologist and Patient Attitudes Toward Yoga as a Therapy for Irritable Bowel Syndrome: An Application of the Theory of Planned Behaviour.
    J Can Assoc Gastroenterol. 2022;6:17-25.
    PubMed    
    Abstract available
    
    

33. LIDDLE RA
    Guanylyl cyclase C ameliorates visceral pain: an unsuspected link.
    J Clin Invest. 2023;133:e166703.
    PubMed    
    Abstract available
    
    

34. ATKINS M, Burton Murray H, Staller K
    Assessment and management of disorders of gut-brain interaction in patients with eating disorders.
    J Eat Disord. 2023;11:20.
    PubMed    
    Abstract available
    
    

35. PLANTINGA AM, Kamp KJ, Wu Q, Chen L, et al
    Exploration of associations among dietary tryptophan, microbiome composition and function, and symptom severity in irritable bowel syndrome.
    Neurogastroenterol Motil. 2023 Feb 13:e14545. doi: 10.1111/nmo.14545.
    PubMed    
    Abstract available
    
    

36. ZHANG VR, Ramachandran GK, Loo EXL, Soh AYS, et al
    Volatile organic compounds as potential biomarkers of irritable bowel syndrome: A systematic review.
    Neurogastroenterol Motil. 2023 Feb 13:e14536. doi: 10.1111/nmo.14536.
    PubMed    
    Abstract available
    
    

37. SAYRE CL, Yellepeddi VK, Job KM, Krepkova LV, et al
    Current use of complementary and conventional medicine for treatment of pediatric patients with gastrointestinal disorders.
    Front Pharmacol. 2023;14:1051442.
    PubMed    
    Abstract available
    
    

38. CHANG WY, Yang YT, She MP, Tu CH, et al
    5-HT(7) receptor-dependent intestinal neurite outgrowth contributes to visceral hypersensitivity in irritable bowel syndrome.
    Lab Invest. 2022;102:1023-1037.
    PubMed    
    Abstract available
    
    

39. CHEN H, Ou R, Tang N, Su W, et al
    Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data.
    J Transl Med. 2023;21:117.
    PubMed    
    Abstract available
    
    

40. WAHID M, Saqib F, Akhtar S, Ali A, et al
    Mechanistic insights of Cucumis melo L. seeds for gastrointestinal muscle spasms through calcium signaling pathway-related gene regulation networks in WGCNA and in vitro, in vivo studies.
    Comput Biol Med. 2023;155:106596.
    PubMed    
    Abstract available
    
    

41. GUGELMO G, Vitturi N, Francini-Pesenti F, Fasan I, et al
    Gastrointestinal Manifestations and Low-FODMAP Protocol in a Cohort of Fabry Disease Adult Patients.
    Nutrients. 2023;15:658.
    PubMed    
    Abstract available
    
    

42. QIU Z, Dai X, Fan C, Cao Y, et al
    A New Regioselective Synthesis of the Cysteine-Rich Peptide Linaclotide.
    Molecules. 2023;28:1007.
    PubMed    
    Abstract available
    
    

43. LI C, Chen Y, Chen Y, Ying Z, et al
    The Causal Association of Irritable Bowel Syndrome with Multiple Disease Outcomes: A Phenome-Wide Mendelian Randomization Study.
    J Clin Med. 2023;12:1106.
    PubMed    
    Abstract available
    
    

44. WANZL J, Grohl K, Kafel A, Nagl S, et al
    Impact of Small Intestinal Bacterial Overgrowth in Patients with Inflammatory Bowel Disease and Other Gastrointestinal Disorders-A Retrospective Analysis in a Tertiary Single Center and Review of the Literature.
    J Clin Med. 2023;12:935.
    PubMed    
    Abstract available
    
    

45. RODINO-JANEIRO BK, Pigrau M, Salvo-Romero E, Nieto A, et al
    Acute Stress Regulates Sex-Related Molecular Responses in the Human Jejunal Mucosa: Implications for Irritable Bowel Syndrome.
    Cells. 2023;12:423.
    PubMed    
    Abstract available
    
    

46. OHKUSA T, Nishikawa Y, Sato N
    Gastrointestinal disorders and intestinal bacteria: Advances in research and applications in therapy.
    Front Med (Lausanne). 2023;9:935676.
    PubMed    
    Abstract available
    
    

47. LIU C, Su W, Tan Z, Zhang J, et al
    The interaction between microbiota and immune in intestinal inflammatory diseases: Global research status and trends.
    Front Cell Infect Microbiol. 2023;13:1128249.
    PubMed    
    Abstract available
    
    

48. SO D, Quigley EMM, Whelan K
    Probiotics in irritable bowel syndrome and inflammatory bowel disease: review of mechanisms and effectiveness.
    Curr Opin Gastroenterol. 2023;39:103-109.
    PubMed    
    Abstract available
    
    

49. MU HY, Wu MP, Wang IT, Wu JC, et al
    Overactive bladder with urodynamic study-induced bladder pain: An overactive bladder subtype with symptoms similar to those of interstitial cystitis/painful bladder syndrome.
    Medicine (Baltimore). 2023;102:e32790.
    PubMed    
    Abstract available
    
    

50. MACINTOSH A, Heenan PE, Wright-McNaughton M, Frampton C, et al
    The relationship between fermentable carbohydrates and post-prandial bowel symptoms in patients with functional bowel disorders.
    Front Nutr. 2023;10:1060928.
    PubMed    
    Abstract available
    
    

51. GUO JG, Rao YF, Jiang J, Li X, et al
    MicroRNA-155-5p inhibition alleviates irritable bowel syndrome by increasing claudin-1 and ZO-1 expression.
    Ann Transl Med. 2023;11:34.
    PubMed    
    Abstract available
    
    

52. WANG X, Shao L, Hua H, Chen Y, et al
    Metabotropic glutamate receptor-8 relieves neonatal maternal separation-induced visceral hypersensitivity in rats by regulating expression of TNF-alpha.
    Ann Transl Med. 2023;11:118.
    PubMed    
    Abstract available
    
    

53. CLUDIUS B, Hummel J, Limburg K, Woud ML, et al
    Development and validation of the ambiguous scenario task for perfectionistic concerns for university students.
    J Behav Ther Exp Psychiatry. 2023;79:101811.
    PubMed    
    Abstract available
    
    

54. TABATA K, Mihara H, Nanjo S, Motoo I, et al
    Artificial intelligence model for analyzing colonic endoscopy images to detect changes associated with irritable bowel syndrome.
    PLOS Digit Health. 2023;2:e0000058.
    PubMed    
    Abstract available
    
    

55. IACOVOU M, Lewis JD
    Commentary: When applying dietary therapies for gastrointestinal conditions, family values, culture, and social challenges matter.
    Nutr Rev. 2023 Feb 21:nuad014. doi: 10.1093.
    PubMed    
    Abstract available
    
    

56. LI KW, Chu HR, Ruan JR, Wang JJ, et al
    [Effect of moxibustion on immune function homeostasis in rats with diarrhea irritable bowel syndrome based on SCF/c-kit signaling pathway].
    Zhongguo Zhen Jiu. 2023;43:177-85.
    PubMed    
    Abstract available
    
    

57. WANG XJ, Ebbert JO, Loftus CG, Rosedahl JK, et al
    Comorbid extra-intestinal central sensitization conditions worsen irritable bowel syndrome in primary care patients.
    Neurogastroenterol Motil. 2023 Feb 19:e14546. doi: 10.1111/nmo.14546.
    PubMed    
    Abstract available
    
    

58. ZHANG H, Wang Z, Wang G, Song X, et al
    Understanding the Connection between Gut Homeostasis and Psychological Stress.
    J Nutr. 2023 Jan 31:S0022-3166(23)05529-3. doi: 10.1016/j.tjnut.2023.
    PubMed    
    Abstract available
    
    

59. GAO X, Tian S, Huang N, Sun G, et al
    Associations of daily sedentary behavior, physical activity, and sleep with irritable bowel syndrome: A prospective analysis of 362,193 participants.
    J Sport Health Sci. 2023 Feb 17:S2095-2546(23)00015.
    PubMed    
    Abstract available
    
    

60. WANG L, Alexander JA
    Letter: diet-responsive or just diet-adherent in EoE. Where is the dietitian? Authors' reply.
    Aliment Pharmacol Ther. 2023;57:445.
    PubMed    
    
    
    

61. EBELL MH
    Low FODMAP Diet Most Likely to Improve Symptoms in Patients With Irritable Bowel Syndrome.
    Am Fam Physician. 2023;107:199-200.
    PubMed    
    
    
    

62. JONES MP, Guthrie-Lyons L, Sato YA, Talley NJ, et al
    Factors Associated With Placebo Treatment Response in Functional Dyspepsia Clinical Trials.
    Am J Gastroenterol. 2022 Dec 20. doi: 10.14309/ajg.0000000000002097.
    PubMed    
    Abstract available
    
    

63. BAI T, Xu Z, Xia P, Feng Y, et al
    The Short-term Efficacy of Bifidobacterium Quadruple Viable Tablet in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: Potentially Mediated by Metabolism rather than Diversity Regulation.
    Am J Gastroenterol. 2022 Dec 23. doi: 10.14309/ajg.0000000000002147.
    PubMed    
    Abstract available
    
    

64. SALEH ZM, Chey WD, Berry S
    Behavioral Health Digital Therapeutics for Patients with Irritable Bowel Syndrome: A Primer for Gastroenterologists.
    Am J Gastroenterol. 2023 Feb 16. doi: 10.14309/ajg.0000000000002220.
    PubMed    
    
    
    

65. LIN M, Hu G, Wang Z, Yu B, et al
    Activation of the High-Affinity Choline Transporter 1 in the Spinal Cord Relieves Stress-Induced Hyperalgesia.
    Dig Dis Sci. 2023 Feb 18. doi: 10.1007/s10620-022-07765.
    PubMed    
    Abstract available
    
    

66. ROKKAS T, Hold GL
    A systematic review, pairwise meta-analysis and network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in irritable bowel syndrome.
    Eur J Gastroenterol Hepatol. 2023 Jan 31. doi: 10.1097/MEG.0000000000002519.
    PubMed    
    Abstract available
    
    

67. BULMER D
    Neuroactive changes in the bowel of patients with IBS on low FODMAP diet: another piece of the puzzle.
    Gut. 2023 Feb 3:gutjnl-2022-329184. doi: 10.1136/gutjnl-2022-329184.
    PubMed    
    
    
    

68. TANAKA Y, Yamashita R, Kawashima J, Mori H, et al
    Further notice of omics profiles of fecal and oral microbiota change in irritable bowel syndrome patients with diarrhea and symptom exacerbation.
    J Gastroenterol. 2023 Feb 7. doi: 10.1007/s00535-022-01951.
    PubMed    
    
    
    

69. SAHIN NU, Sahin N, Kilic M
    Effect of comorbid benign joint hypermobility and juvenile fibromyalgia syndromes on pediatric functional gastrointestinal disorders.
    Postgrad Med. 2023 Feb 1. doi: 10.1080/00325481.2023.2176637.
    PubMed    
    Abstract available
    
    

70. STEINSVIK EK, Hausken T, Fluge O, Mella O, et al
    Gastric dysmotility and gastrointestinal symptoms in myalgic encephalomyelitis/chronic fatigue syndrome.
    Scand J Gastroenterol. 2023 Feb 2:1-8. doi: 10.1080/00365521.2023.2173533.
    PubMed    
    Abstract available
    
    

71. TORNKVIST NT, Backman AS, Linder M, Altman M, et al
    Identification of irritable bowel syndrome in the Swedish National Patient Register: a validation study.
    Scand J Gastroenterol. 2023 Feb 1:1-9. doi: 10.1080/00365521.2023.2173021.
    PubMed    
    Abstract available
    
    

72. SCHALLER A, Vanderzande S, Peace C
    Deducing genotypes for loci of interest from SNP array data via haplotype sharing, demonstrated for apple and cherry.
    PLoS One. 2023;18:e0272888.
    PubMed    
    Abstract available